Listed

Definitive Healthcare Corp.

DHNasdaqCIK 1861795TechnologyFiscal year ends Dec 31

Latest reported revenue, Q2 FY2026$55.2mRevenue, Q2 FY2026, three months to 2026-06-30$55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figureThree months to Jun 30, 2026, from the 10-Q filed Aug 10, 2026.

Latest quarter: Q2 FY2026

Three months to Jun 30, 2026, against the same quarter a year earlier.

  • Revenue$55.2mRevenue, Q2 FY2026, three months to 2026-06-30$55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure−9.1% on a year earlier
  • Gross margin73.5%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $40.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure−3.3 pts on a year earlier
  • Operating margin−12.2%Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure−5.4 pts on a year earlier
  • Net margin−9.8%Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure+2.6 pts on a year earlier
  • Diluted EPS−$0.05Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure+28.6% on a year earlier
  • Free cash flow$8.5mFree cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure+21.4% on a year earlier

Last eight quarters

Full statements
Revenue$55.2mGross margin 73.5%
Diluted EPS−$0.05, Q2 FY2026
Free cash flow$8.5m, Q2 FY2026
Definitive Healthcare Corp., key figures for the last eight quarters
Line itemUnitQ3 FY20242024-09-30Q4 FY20242024-12-31Q1 FY20252025-03-31Q2 FY20252025-06-30Q3 FY20252025-09-30Q4 FY20252025-12-31Q1 FY20262026-03-31Q2 FY20262026-06-30Shape over the periods
Revenue$m62.7Revenue, Q3 FY2024, three months to 2024-09-30$62.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure62.3Revenue, Q4 FY2024, three months to 2024-12-31$62.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure59.2Revenue, Q1 FY2025, three months to 2025-03-31$59.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure60.8Revenue, Q2 FY2025, three months to 2025-06-30$60.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure60.0Revenue, Q3 FY2025, three months to 2025-09-30$60.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure61.5Revenue, Q4 FY2025, three months to 2025-12-31$61.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure55.9Revenue, Q1 FY2026, three months to 2026-03-31$55.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure55.2Revenue, Q2 FY2026, three months to 2026-06-30$55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Gross margin%78.2%Gross margin, Q3 FY2024, three months to 2024-09-30. gross profit / revenueGross profit: $49.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Revenue: $62.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure76.4%Gross margin, Q4 FY2024, three months to 2024-12-31. gross profit / revenueGross profit: $47.6m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Revenue: $62.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure73.9%Gross margin, Q1 FY2025, three months to 2025-03-31. gross profit / revenueGross profit: $43.8m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Revenue: $59.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure76.7%Gross margin, Q2 FY2025, three months to 2025-06-30. gross profit / revenueGross profit: $46.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $60.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure76.6%Gross margin, Q3 FY2025, three months to 2025-09-30. gross profit / revenueGross profit: $46.0m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Revenue: $60.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure76.2%Gross margin, Q4 FY2025, three months to 2025-12-31. gross profit / revenueGross profit: $46.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Revenue: $61.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure74.5%Gross margin, Q1 FY2026, three months to 2026-03-31. gross profit / revenueGross profit: $41.6m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Revenue: $55.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure73.5%Gross margin, Q2 FY2026, three months to 2026-06-30. gross profit / revenueGross profit: $40.5m. XBRL concept us-gaap:GrossProfit. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Operating margin%(359.5%)Operating margin, Q3 FY2024, three months to 2024-09-30. operating income / revenueOperating income: −$225.4m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Revenue: $62.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(159.8%)Operating margin, Q4 FY2024, three months to 2024-12-31. operating income / revenueOperating income: −$99.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Revenue: $62.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(312.2%)Operating margin, Q1 FY2025, three months to 2025-03-31. operating income / revenueOperating income: −$184.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Revenue: $59.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(6.9%)Operating margin, Q2 FY2025, three months to 2025-06-30. operating income / revenueOperating income: −$4.2m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $60.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure(14.5%)Operating margin, Q3 FY2025, three months to 2025-09-30. operating income / revenueOperating income: −$8.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Revenue: $60.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(43.3%)Operating margin, Q4 FY2025, three months to 2025-12-31. operating income / revenueOperating income: −$26.6m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Revenue: $61.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(359.9%)Operating margin, Q1 FY2026, three months to 2026-03-31. operating income / revenueOperating income: −$201.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Revenue: $55.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(12.2%)Operating margin, Q2 FY2026, three months to 2026-06-30. operating income / revenueOperating income: −$6.7m. XBRL concept us-gaap:OperatingIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Net margin%(208.8%)Net margin, Q3 FY2024, three months to 2024-09-30. net income / revenueNet income: −$130.9m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Revenue: $62.7m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(94.8%)Net margin, Q4 FY2024, three months to 2024-12-31. net income / revenueNet income: −$59.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Revenue: $62.3m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(181.2%)Net margin, Q1 FY2025, three months to 2025-03-31. net income / revenueNet income: −$107.2m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Revenue: $59.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(12.4%)Net margin, Q2 FY2025, three months to 2025-06-30. net income / revenueNet income: −$7.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $60.8m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure(24.7%)Net margin, Q3 FY2025, three months to 2025-09-30. net income / revenueNet income: −$14.8m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Revenue: $60.0m. XBRL concept us-gaap:Revenues. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figure(15.1%)Net margin, Q4 FY2025, three months to 2025-12-31. net income / revenueNet income: −$9.3m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Revenue: $61.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure(247.9%)Net margin, Q1 FY2026, three months to 2026-03-31. net income / revenueNet income: −$138.6m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Revenue: $55.9m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(9.8%)Net margin, Q2 FY2026, three months to 2026-06-30. net income / revenueNet income: −$5.4m. XBRL concept us-gaap:NetIncomeLoss. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Revenue: $55.2m. XBRL concept us-gaap:Revenues. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Diluted EPS$ per share(1.12)Diluted EPS, Q3 FY2024, three months to 2024-09-30−$1.12 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figurenot reported (Diluted EPS not reported)(0.95)Diluted EPS, Q1 FY2025, three months to 2025-03-31−$0.95 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(0.07)Diluted EPS, Q2 FY2025, three months to 2025-06-30−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure(0.14)Diluted EPS, Q3 FY2025, three months to 2025-09-30−$0.14 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2025-11-06, accession 0001193125-25-269681.Report this figurenot reported (Diluted EPS not reported)(1.32)Diluted EPS, Q1 FY2026, three months to 2026-03-31−$1.32 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure(0.05)Diluted EPS, Q2 FY2026, three months to 2026-06-30−$0.05 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-Q filed 2026-08-10, accession 0001193125-26-342488.Report this figure
Free cash flow$m18.7Free cash flow, Q3 FY2024, three months to 2024-09-30. operating cash flow − capital expenditureOperating cash flow: $19.4m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Capital expenditure: $767.0k. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure(2.8)Free cash flow, Q4 FY2024, three months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $8.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Capital expenditure: $10.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure18.4Free cash flow, Q1 FY2025, three months to 2025-03-31. operating cash flow − capital expenditureOperating cash flow: $26.1m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Capital expenditure: $7.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure7.0Free cash flow, Q2 FY2025, three months to 2025-06-30. operating cash flow − capital expenditureOperating cash flow: $9.3m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure13.4Free cash flow, Q3 FY2025, three months to 2025-09-30. operating cash flow − capital expenditureOperating cash flow: $15.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Capital expenditure: $2.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2025-11-06, accession 0001193125-25-269681. Derived: 9-month figure less the 6-month figure.Report this figure(1.7)Free cash flow, Q4 FY2025, three months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $2.7m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Capital expenditure: $4.4m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782. Derived: 12-month figure less the 9-month figure.Report this figure8.4Free cash flow, Q1 FY2026, three months to 2026-03-31. operating cash flow − capital expenditureOperating cash flow: $11.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Capital expenditure: $3.2m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-05-07, accession 0001193125-26-212063.Report this figure8.5Free cash flow, Q2 FY2026, three months to 2026-06-30. operating cash flow − capital expenditureOperating cash flow: $11.5m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Capital expenditure: $2.9m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-Q filed 2026-08-10, accession 0001193125-26-342488. Derived: 6-month figure less the 3-month figure.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Last five fiscal years

Revenue$241.5mGross margin 75.9%
Diluted EPS−$1.30, FY2025
Free cash flow$37.1m, FY2025
Definitive Healthcare Corp., key figures for the last five fiscal years
Line itemUnitFY20212021-12-31FY20222022-12-31FY20232023-12-31FY20242024-12-31FY20252025-12-31Shape over the periods
Revenue$m166Revenue, FY2021, twelve months to 2021-12-31$166.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-28, accession 0000950170-24-022134.Report this figure223Revenue, FY2022, twelve months to 2022-12-31$222.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure251Revenue, FY2023, twelve months to 2023-12-31$251.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure252Revenue, FY2024, twelve months to 2024-12-31$252.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure242Revenue, FY2025, twelve months to 2025-12-31$241.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure
Gross margin%75.5%Gross margin, FY2021, twelve months to 2021-12-31. gross profit / revenueGross profit: $125.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2024-02-28, accession 0000950170-24-022134.Revenue: $166.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-28, accession 0000950170-24-022134.Report this figure80.9%Gross margin, FY2022, twelve months to 2022-12-31. gross profit / revenueGross profit: $180.0m. XBRL concept us-gaap:GrossProfit. 10-K filed 2025-02-27, accession 0000950170-25-029086.Revenue: $222.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure81.1%Gross margin, FY2023, twelve months to 2023-12-31. gross profit / revenueGross profit: $203.9m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $251.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure78.3%Gross margin, FY2024, twelve months to 2024-12-31. gross profit / revenueGross profit: $197.5m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $252.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure75.9%Gross margin, FY2025, twelve months to 2025-12-31. gross profit / revenueGross profit: $183.3m. XBRL concept us-gaap:GrossProfit. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $241.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure
Operating margin%(16.4%)Operating margin, FY2021, twelve months to 2021-12-31. operating income / revenueOperating income: −$27.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2024-02-28, accession 0000950170-24-022134.Revenue: $166.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-28, accession 0000950170-24-022134.Report this figure(19.8%)Operating margin, FY2022, twelve months to 2022-12-31. operating income / revenueOperating income: −$44.0m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2025-02-27, accession 0000950170-25-029086.Revenue: $222.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure(131.2%)Operating margin, FY2023, twelve months to 2023-12-31. operating income / revenueOperating income: −$329.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $251.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure(281.8%)Operating margin, FY2024, twelve months to 2024-12-31. operating income / revenueOperating income: −$710.8m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $252.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure(92.9%)Operating margin, FY2025, twelve months to 2025-12-31. operating income / revenueOperating income: −$224.3m. XBRL concept us-gaap:OperatingIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $241.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure
Net margin%(10.7%)Net margin, FY2021, twelve months to 2021-12-31. net income / revenueNet income: −$17.8m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2024-02-28, accession 0000950170-24-022134.Revenue: $166.2m. XBRL concept us-gaap:Revenues. 10-K filed 2024-02-28, accession 0000950170-24-022134.Report this figure(3.2%)Net margin, FY2022, twelve months to 2022-12-31. net income / revenueNet income: −$7.2m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2025-02-27, accession 0000950170-25-029086.Revenue: $222.7m. XBRL concept us-gaap:Revenues. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure(80.5%)Net margin, FY2023, twelve months to 2023-12-31. net income / revenueNet income: −$202.4m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $251.4m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure(163.8%)Net margin, FY2024, twelve months to 2024-12-31. net income / revenueNet income: −$413.1m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $252.2m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure(57.5%)Net margin, FY2025, twelve months to 2025-12-31. net income / revenueNet income: −$138.9m. XBRL concept us-gaap:NetIncomeLoss. 10-K filed 2026-02-26, accession 0001193125-26-076782.Revenue: $241.5m. XBRL concept us-gaap:Revenues. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure
Diluted EPS$ per share(0.19)Diluted EPS, FY2021, twelve months to 2021-12-31−$0.19 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2024-02-28, accession 0000950170-24-022134.Report this figure(0.07)Diluted EPS, FY2022, twelve months to 2022-12-31−$0.07 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure(1.79)Diluted EPS, FY2023, twelve months to 2023-12-31−$1.79 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure(3.54)Diluted EPS, FY2024, twelve months to 2024-12-31−$3.54 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure(1.30)Diluted EPS, FY2025, twelve months to 2025-12-31−$1.30 per share. XBRL concept us-gaap:EarningsPerShareDiluted. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure
Free cash flow$m18.5Free cash flow, FY2021, twelve months to 2021-12-31. operating cash flow − capital expenditureOperating cash flow: $25.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2024-02-28, accession 0000950170-24-022134.Capital expenditure: $6.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2024-02-28, accession 0000950170-24-022134.Report this figure27.3Free cash flow, FY2022, twelve months to 2022-12-31. operating cash flow − capital expenditureOperating cash flow: $35.6m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2025-02-27, accession 0000950170-25-029086.Capital expenditure: $8.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2025-02-27, accession 0000950170-25-029086.Report this figure38.2Free cash flow, FY2023, twelve months to 2023-12-31. operating cash flow − capital expenditureOperating cash flow: $41.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782.Capital expenditure: $3.0m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure45.9Free cash flow, FY2024, twelve months to 2024-12-31. operating cash flow − capital expenditureOperating cash flow: $58.2m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782.Capital expenditure: $12.3m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure37.1Free cash flow, FY2025, twelve months to 2025-12-31. operating cash flow − capital expenditureOperating cash flow: $53.8m. XBRL concept us-gaap:NetCashProvidedByUsedInOperatingActivities. 10-K filed 2026-02-26, accession 0001193125-26-076782.Capital expenditure: $16.7m. XBRL concept us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. 10-K filed 2026-02-26, accession 0001193125-26-076782.Report this figure

Focus or hover a figure to see its XBRL concept, period and filing; each links to that filing. A figure marked d is derived: a quarter computed from year-to-date figures, such as the fourth quarter as the fiscal year less the nine months before it. A ratio reads not reported when any input is missing.

Insider purchases and sales

All insider transactions

The last 20 open-market transactions reported on Form 4 (codes P and S). The reported price is the price per share the insider stated on the form: filing data, not a market price.

No open-market purchases or sales by insiders are in coverage from Nov 2024 to Oct 2026.

No open-market purchases or sales by insiders are in coverage for this company.

Funds that report holding it

All funds

From each manager's latest Form 13F, largest reported value first. Reported value is as filed at the quarter end: filing data, not a price. A put or call is an option position, not shares held.

Funds that report holding Definitive Healthcare Corp.
FundQuarter endedReported valueSharesPut or callChange on the quarter before
Advent International, L.P.2026-06-30$51.9m62,493,676Unchanged
GOLDMAN SACHS GROUP INC2026-06-30$5.0m5,959,143Reduced−84,757
D. E. Shaw & Co., Inc.2026-06-30$1.6m1,973,193Reduced−126,358
VANGUARD CAPITAL MANAGEMENT LLC2026-06-30$1.5m1,829,463Reduced−36,866
KENNEDY CAPITAL MANAGEMENT LLC2026-06-30$1.4m1,737,044New+1,737,044
DIMENSIONAL FUND ADVISORS LP2026-06-30$1.2m1,453,209Reduced−213,160
BlackRock, Inc.2026-06-30$1.2m1,408,621Reduced−1,576,946
AQR CAPITAL MANAGEMENT LLC2026-06-30$747.1k899,132Added+197,109
GEODE CAPITAL MANAGEMENT, LLC2026-06-30$457.9k550,753Reduced−628,941
RENAISSANCE TECHNOLOGIES LLC2026-06-30$436.3k525,040Added+13,900

Recent filings

All 384 filings

Reports and events: 10-K, 10-Q, 8-K, proxy statements and ownership schedules.

Definitive Healthcare Corp., recent filings
FiledFormWhat it isAccession number
2026-10-0120:30 ETSCHEDULE 13D/AOwnership report, active investor, amended0001140361-26-038313
2026-09-0908:30 ET8-K7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits0001193125-26-385950
2026-09-0209:16 ET8-K8.01 Other events; 9.01 Financial statements and exhibits0001193125-26-379460
2026-09-0208:40 ETSCHEDULE 13DOwnership report, active investor0001193125-26-379428
2026-09-0208:31 ET8-K5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits0001193125-26-379420
2026-09-0208:30 ETSCHEDULE 13DOwnership report, active investor0001140361-26-035412
2026-08-1016:30 ET10-QQuarterly reportPeriod 2026-06-300001193125-26-342488
2026-08-1016:10 ET8-K2.02 Results of operations; 9.01 Financial statements and exhibits0001193125-26-342384
2026-06-2416:05 ET8-K3.01 Delisting notice0001193125-26-281037
2026-06-0516:05 ET8-K5.07 Shareholder vote results0001193125-26-259530

Latest annual report

Form 10-K for the fiscal year ended Dec 31, 2025Filed Feb 26, 2026. Its page lists the documents and the extracted sections, such as Business and Risk factors.

Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by [object Promise].Forecast this quarter

About the filer

CIK
1861795
Tickers
DH
Exchange
Nasdaq
SIC code
7372 Services-Prepackaged Software
Sector
Technology
Fiscal year ends
Dec 31
Incorporated in
DE
Filer category
Accelerated filer<br>Smaller reporting company

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 27, 2026, 16:07 ET. Listed shows no prices and gives no investment advice.